Cargando…

A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

Irritable bowel syndrome (IBS), one of the most frequent digestive disorders, is characterized by chronic and recurrent abdominal pain and altered bowel habit. The origin seems to be multifactorial and is still not well defined for the different subtypes. Genetic, epigenetic and sex-related modifica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodiño-Janeiro, Bruno K., Vicario, María, Alonso-Cotoner, Carmen, Pascua-García, Roberto, Santos, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859043/ https://www.ncbi.nlm.nih.gov/pubmed/29498019 http://dx.doi.org/10.1007/s12325-018-0673-5

Ejemplares similares

Role of Corticotropin-releasing Factor in Gastrointestinal Permeability
por: Rodiño-Janeiro, Bruno K, et al.
Publicado: (2015)

Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome
por: Salvo-Romero, Eloísa, et al.
Publicado: (2020)

Acute Stress Regulates Sex-Related Molecular Responses in the Human Jejunal Mucosa: Implications for Irritable Bowel Syndrome
por: Rodiño-Janeiro, Bruno K., et al.
Publicado: (2023)

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations
por: Pardo-Camacho, Cristina, et al.
Publicado: (2022)

Blastocystis sp. Carriage and Irritable Bowel Syndrome: Is the Association Already Established?
por: Salvador, Fernando, et al.
Publicado: (2021)

The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults
por: Alonso-Cotoner, Carmen, et al.
Publicado: (2021)

Cellular and Molecular Basis of Intestinal Barrier Dysfunction in the Irritable Bowel Syndrome
por: Martínez, Cristina, et al.
Publicado: (2012)

Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
por: Stern, Emily K, et al.
Publicado: (2018)

Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction
por: Rodiño-Janeiro, Bruno K., et al.
Publicado: (2018)

Irritable Bowel Syndrome, Gut Microbiota and Probiotics
por: Lee, Beom Jae, et al.
Publicado: (2011)

Gut Microbiota Manipulation in Irritable Bowel Syndrome
por: Mazzawi, Tarek
Publicado: (2022)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants
por: Alemany, Silvia, et al.
Publicado: (2023)

The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?
por: Ghoshal, Uday C., et al.
Publicado: (2012)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
por: Bennet, Sean M.P., et al.
Publicado: (2015)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022)

Gut microbiota signatures and modulation in irritable bowel syndrome
por: Marasco, Giovanni, et al.
Publicado: (2022)

The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review
por: Shrestha, Bijay, et al.
Publicado: (2022)

Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives
por: FJELDHEIM DALE, Hanna, et al.
Publicado: (2020)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy
por: Chong, Pei Pei, et al.
Publicado: (2019)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
por: Mishima, Yoshiyuki, et al.
Publicado: (2020)

Dietary modulation of gut microbiota for the relief of irritable bowel syndrome
por: Kim, Mi-Young, et al.
Publicado: (2021)

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
por: Wollny, Tomasz, et al.
Publicado: (2021)

Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
por: Mamieva, Zarina, et al.
Publicado: (2022)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Corrigendum: The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy
por: Chong, Pei Pei, et al.
Publicado: (2019)

The Immune System in Irritable Bowel Syndrome
por: Barbara, Giovanni, et al.
Publicado: (2011)

No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls
por: Dlugosz, Aldona, et al.
Publicado: (2015)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Irritable Bowel Syndrome: Yoga as Remedial Therapy
por: Kavuri, Vijaya, et al.
Publicado: (2015)

Mechanism-Oriented Therapy of Irritable Bowel Syndrome
por: Malagelada, Juan R., et al.
Publicado: (2016)

Probiotic Yeast Therapy for Irritable Bowel Syndrome
por: Pélerin, Fanny, et al.
Publicado: (2016)

Therapy of the postinfectious irritable bowel syndrome: an update
por: IACOB, TEODORA, et al.
Publicado: (2017)

Eosinophils in the Gastrointestinal Tract: Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction
por: Salvo-Romero, Eloísa, et al.
Publicado: (2022)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f9nom61kb43hgjkjueaiffm0v9